Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors-an autopsy study
about
Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature.History and current state of immunotherapy in glioma and brain metastasis.Immune Checkpoint Inhibition and the Prevalence of Autoimmune Disorders Among Patients With Lung and Renal Cancer.Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitisFulminant Myocarditis with Combination Immune Checkpoint Blockade.Cardiovascular Complications Associated With Novel Cancer Immunotherapies.Nivolumab in melanoma.Cardiovascular Toxicities Associated with Cancer Immunotherapies.Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.Immune Checkpoint Inhibitors for Brain Metastases.Two cases of melanomas paradoxically metastasizing to the intestinal tract during nivolumab therapy.[Lymphocytic myocarditis in a patient with metastatic clear cell renal cell carcinoma treated with Nivolumab].Acute hypophysitis secondary to nivolumab immunotherapy in a patient with metastatic melanomaNivolumab-induced Acute Fibrinous and Organizing Pneumonia (AFOP)Evaluation of rare but severe immune related adverse effects in PD-1 and PD-L1 inhibitors in non-small cell lung cancer: a meta-analysis.Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report.Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects.Melanoma patient response to nivolumab treatment for metastatic lung lesions: Multi-OMICS analysis in Project HOPE.Immune checkpoint inhibitor-related myocarditis.Fatal Myocarditis Following Treatment with the PD-1 Inhibitor Nivolumab.High incidence and early onset of nivolumab-induced pneumonitis: four case reports and literature review.Fatal Necrotizing Encephalopathy after Treatment with Nivolumab for Squamous Non-Small Cell Lung Cancer: Case Report and Review of the Literature.Diffuse edema suggestive of cytokine release syndrome in a metastatic lung carcinoma patient treated with pembrolizumab.Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab.[The pathology of adverse events with immune checkpoint inhibitors].Sarcoid-like reactions in patients receiving modern melanoma treatment.Cardiotoxicity of immune checkpoint inhibitors.Anti PD-1 immunotherapy related interstitial lung disease presenting as respiratory failure - A review with case series
P2860
Q30275135-C62E43C2-F27D-4A91-BC46-DA074C0A4657Q33656811-5C1F9A82-00F4-476D-A9E2-2D0E9FE8E600Q33764931-685E8E8B-97EB-4201-8E97-3E3A4A502354Q33813378-E38BDE21-6EC7-4335-B422-C3869C8A6F73Q37595462-939219A8-62B5-4BD3-BE33-0D90E2878209Q38731522-748D5804-7FA3-4A5C-B5DB-245B19EF4A67Q38989508-AE3DFFE3-AB0F-4850-A790-05897781CC17Q39144916-B87546B6-394C-4BD7-9A98-AC33704E6970Q39161011-BBA007F9-9A29-4D1A-89FB-A507848E0962Q39247421-1D281AC9-5322-44FF-A4FE-35E4CE5944F2Q40065192-2AAA7D23-4330-4451-B370-C746E312EDABQ40078647-9CA72D5F-DB31-4210-B1F0-BE174132CEA0Q42066160-A4EE2BEC-AE37-487F-A6AD-82B1F607A58DQ42264783-513A72BC-C49E-4A50-9D36-3E752D8E398DQ47131539-9E3211E8-90F1-4300-BBFE-F0F5DA62C85AQ47148480-8E8C75A1-BCFE-41DF-BC2C-DD3A13ACEC16Q47239900-EE3B7F87-AC49-40C3-98F8-90D9A1AB4314Q47577369-F66ECBAB-1C3E-4B83-8F78-5093A4C5DDB2Q47633085-8BC749DE-15A6-41D5-BFA1-DF4FE38A300AQ47916862-717E1A84-E2AE-47DA-A821-EF8D3826130BQ48148720-D6D2743D-D09D-4C4C-AEBF-B1903ED78B23Q49231401-21000D82-1BFA-4CA9-8644-61D09AD04A6DQ51095574-795DC3FE-294E-46A2-A23C-839D22445A9FQ52759933-9D388B8C-0E32-4F1E-A8D9-2B651C293464Q52879625-42CCFF3C-5823-49A0-821B-022CD3A1A371Q54982896-A80AB217-C0F2-4C1B-9229-8591CB5D9E41Q55438414-430021DB-3D73-47F1-A476-3CD846136B98Q59129657-656AEBD8-DCAF-464F-99B2-25AF838E00FB
P2860
Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors-an autopsy study
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Systemic inflammation in a mel ...... nt inhibitors-an autopsy study
@ast
Systemic inflammation in a mel ...... nt inhibitors-an autopsy study
@en
type
label
Systemic inflammation in a mel ...... nt inhibitors-an autopsy study
@ast
Systemic inflammation in a mel ...... nt inhibitors-an autopsy study
@en
prefLabel
Systemic inflammation in a mel ...... nt inhibitors-an autopsy study
@ast
Systemic inflammation in a mel ...... nt inhibitors-an autopsy study
@en
P2093
P2860
P921
P1476
Systemic inflammation in a mel ...... nt inhibitors-an autopsy study
@en
P2093
Alfred Zippelius
Berenika Willi
Deborah Zihler
Gieri Cathomas
Kirsten D Mertz
Michèle Voegeli
Niels Willi
Sacha I Rothschild
P2860
P2888
P356
10.1186/S40425-016-0117-1
P577
2016-03-15T00:00:00Z
P5875
P6179
1018958891